These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32021444)

  • 1. Siva 1 Inhibits Cervical Cancer Progression and Its Clinical Prognosis Significance.
    Liu T; Ma Y; Wang Z; Zhang W; Yang X
    Cancer Manag Res; 2020; 12():303-311. PubMed ID: 32021444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siva 1 inhibits proliferation, migration and invasion by phosphorylating Stathmin in ovarian cancer cells.
    Ma Y; Liu T; Song X; Tian Y; Wei Y; Wang J; Li X; Yang X
    Oncol Lett; 2017 Aug; 14(2):1512-1518. PubMed ID: 28789373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siva‑1 regulates multidrug resistance of gastric cancer by targeting MDR1 and MRP1 via the NF‑κB pathway.
    Kong FB; Deng QM; Deng HQ; Dong CC; Li L; He CG; Wang XT; Xu S; Mai W
    Mol Med Rep; 2020 Aug; 22(2):1558-1566. PubMed ID: 32626967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.
    Li T; Lv M; Chen X; Yu Y; Zang G; Tang Z
    Drug Des Devel Ther; 2019; 13():1289-1300. PubMed ID: 31118568
    [No Abstract]   [Full Text] [Related]  

  • 5. The miR-133b/brefeldin A-inhibited guanine nucleotide-exchange protein 1 (ARFGEF1) axis represses proliferation, invasion, and migration in cervical cancer cells.
    Jiang L; Wang X
    Bioengineered; 2022 Feb; 13(2):3323-3332. PubMed ID: 35048795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamin 3 overexpression suppresses the proliferation, migration and invasion of cervical cancer cells.
    Fa J
    Oncol Lett; 2021 Jul; 22(1):524. PubMed ID: 34025791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PM2.5 exposure induces alveolar epithelial cell apoptosis and causes emphysema through p53/Siva-1.
    Xu F; Xu A; Guo Y; Bai Q; Wu X; Ji SP; Xia RX
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3943-3950. PubMed ID: 32329870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus-Mediated Overexpression of SIVA-1 Reverses Cisplatin Resistance in Gastric Cancer in vitro.
    Wang XT; Li L; Kong FB; Zhong XG; Mai W
    Cell Biochem Biophys; 2020 Dec; 78(4):455-463. PubMed ID: 32648086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation, Invasion, and Migration in Cervical Cancer.
    Yang R; Ma M; Yu S; Li X; Zhang J; Wu S
    Front Oncol; 2021; 11():742017. PubMed ID: 34671559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
    Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway.
    Liu T; Liu Y; Bao X; Tian J; Liu Y; Yang X
    PLoS One; 2013; 8(9):e75864. PubMed ID: 24086649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
    Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y
    Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
    Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.
    Ouyang F; Liu J; Xia M; Lin C; Wu X; Ye L; Song L; Li J; Wang J; Guo P; He M
    Oncol Rep; 2017 May; 37(5):2652-2662. PubMed ID: 28405687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of miR-337-3p and its target Rap1A in modulating proliferation, invasion, migration and apoptosis of cervical cancer cells.
    Cao XM
    Cancer Biomark; 2019; 24(3):257-267. PubMed ID: 30883336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1.
    Wang JM; Ju BH; Pan CJ; Gu Y; Li MQ; Sun L; Xu YY; Yin LR
    Am J Transl Res; 2017; 9(8):3541-3557. PubMed ID: 28861147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-449a Is Downregulated in Cervical Cancer and Inhibits Proliferation, Migration, and Invasion.
    Wang L; Zhao Y; Xiong W; Ye W; Zhao W; Hua Y
    Oncol Res Treat; 2019; 42(11):564-571. PubMed ID: 31578014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOX-1 is a poor prognostic indicator and induces epithelial-mesenchymal transition and metastasis in pancreatic cancer patients.
    Zhang J; Zhang L; Li C; Yang C; Li L; Song S; Wu H; Liu F; Wang L; Gu J
    Cell Oncol (Dordr); 2018 Feb; 41(1):73-84. PubMed ID: 29168159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer.
    Li G; Wu Q; Gong L; Xu X; Cai J; Xu L; Zeng Y; He X; Wang Z
    Cancer Cell Int; 2021 Oct; 21(1):568. PubMed ID: 34702269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway.
    Shi WJ; Liu H; Ge YF; Wu D; Tan YJ; Shen YC; Wang H; Xu H
    Cytokine; 2020 Dec; 136():155286. PubMed ID: 32950808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.